Is reduced baroreflex gain a component of the metabolic syndrome? Insights from the LINOSA study

Journal of Hypertension

Volumn 24, Issue 2, 2006, Pages 361-370

  Lucini, Daniela ^a   Cusumano, Gaspare ^b   Bellia, Alfonso ^c   Kozakova, Michela ^d   DiFede, Gaetana ^b   Lauro, Renato ^c   Pagani, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Policlinico Palermo   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Autonomic regulation; Baroreflex; Cardiovascular risk; Hypertension; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTERY WALL; ARTICLE; BEHAVIOR; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GENETICS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RR INTERVAL; SINUS NODE; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; SPECTROSCOPY; ULTRASOUND;

EID: 33644804519     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000202817.02836.9c     Document Type: Article

References (55)

1. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998; 32:293-297.
2. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction). Lancet 1998; 351:478-484.
3. Brunner EJ, Hemingway H, Walker BR, Page M, Res M, Clarke P, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 2002; 106:2659-2665.
4. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106:3143-3421.
5. Grundy SM, Brewer BH, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109:433-438.
6. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J 2004; 148:16-26.
7. Hjemdahl P. Stress and the metabolic syndrome. An interesting but enigmatic association. Circulation 2002; 106:2634-2636.
8. Huggett RJ, Burns J, Mackintosh AF, Mary DASG. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44:847-852.
9. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106:2533-2536.
10. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002; 282:H630-H635.
11. Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004; 286:R803-R813.
12. Lucini D, Mela GS, Malliani A, Pagani M. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans. Insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation 2002; 106:2673-2679.
13. Tsai Y-S, Kim H-J, Takahashi N, Kim H-S, Hagaman JR, Kim JK, et al. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ. J Clin Invest 2004; 114:240-249.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
15. Boden G, Hoeldtke RD. Nerves, fat and insulin resistance. N Engl J Med 2003; 349:1966-1972.
16. Kloting N, Kloting WB. Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol Genom 2004; 18:325-330.
17. Räikkönen K, Matthews KA, Sutton-Tirrel K, Kuller L. Trait anger and the metabolic syndrome predict progression of carotid atherosclerosis in healthy middle-aged women. Psychosom Med 2004; 66:903-908.
18. Puato M, Faggin E, Rattazzi M, Paterni M, Kozàkovà M, Palombo C, et al. In vivo, non-invasive identification of cell composition of intimal lesions: combined ultrasound and immunocytochemistry based approach. J Vasc Surg 2003; 38:1390-1395.
19. Lucini D, Norbiato G, Clerici M, Pagani M. Hemodynamic and autonomic adjustments to real life stress conditions in humans. Hypertension 2002; 39:184-188.
20. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study):case control study. Lancet 2004; 364:937-952.
21. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13:647-655.
22. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986; 58:178-193.
23. Task Force - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the Guidelines of Ambulatory electrocardiography). ACC/AHA Guidelines for Ambulatory Electrocardiography: Executive Summary and Recommendations. Circulation 1999; 100:886-893.
24. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett CL, et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997; 95:1441-1448.
25. Pagani M, Somers VK, Furlan R, Dell'Orto S, Conway J, Baselli G, et al. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 1988; 12:600-610.
26. Rajala U, Laasko M, Päivänsalo M, Pelkonen O, Suramo I, Keinänen-Kiukaanniemi S. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima media thickness of the carotid artery. J Clin Endocrinol Metab 2002; 87:5092-5097.
27. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 case and 13648 controls from 52 countries (The INTERHEART study): case control study. Lancet 2004; 364:953-962.
28. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
29. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation 2003; 108:1552-1553.
30. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106:453-458.
31. DeFronzo RA, Tobin JD, Andres R. The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin. Am J Physiol 1979; 237:E214-E223.
32. Bloomgarden ZT. Inflammation and insulin resistance. Diabetes Care 2003; 26:1619-1623.
33. Zampelas A, Panagiotakos DB, Pisavos C, Das UN, Chrysohoou C, Skoumas Y, et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease. J Am Coll Cardiol 2005; 46:120-124.
34. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 1999; 33:698-702.
35. Pikkujämsä SM, Huikuri HV, Airaksjnen KE, Rantala AO, Kauma H, Lilja M, et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998; 11:523-531.
36. van de Borne P, Montano N, Pagani M, Oren RM, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95:1449-1454.
37. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998; 83:2084-2090.
38. Laitinen T, Huopio H, Vauhkonen IK, Camaro C, Hartjkainen J, Laskso M, et al. Effects of euglycaemic and hypoglicaemic hyperinsulinemia on sympathetic and parasympathetic regulation of haemodynamics in healthy subjects. Clin Sci 2003; 105:315-322.
39. Reims HM, Sevre K, Fossum E, Høieggen A, Mellem H, Kjeldsen SE. Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men. J Hypertens 2004; 22:2007-2015.
40. Grassi G, Serravalle G, Colombo M, Bolla GB, Cattaneo BM, Cavagnini F, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97:2037-2042.
41. Mancia G, Ludbrook J, Ferrari A, Gregorini L, Zanchetti A. Baroreceptor reflexes in human hypertension. Circ Res 1978; 43:170-177.
42. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 2000; 18:7-19.
43. Brea A, Mosquera D, Martin E, Aritzi A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis. A case-control study. Arterioscler Thromb Vasc Biol 2005; 25:1045-1050.
44. Emdin M, Gastaldelli A, Muscelli E, Macerata A, Natali A, Camastra S, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 2001; 103:513-519.
45. Malliani A, Pagani M. Interpreting oscillations of muscle sympathetic nerve activity and of heart rate variability. J Hypertens 2000; 18:1709-1719.
46. Pagani M, Pizzinelli P, Bergamaschi M, Malliani A. A positive feedback sympathetic pressor reflex during stretch of the thoracic aorta in conscious dogs. Circ Res 1982; 50:125-132.
47. Motte S, Mathieu M, Brimouille S, Pensis A, Ray L, Ketelslegers JM, et al. Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol (in press).
48. Frattola A, Parati G, Gamba P, Paleari F, Mauri G, Di Rienzo M, et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997; 40:1470-1475.
49. Pelat M, Verwaerde P, Merial C, Galitzky J, Berlan M, Montastruc JL, et al. Impaired atrial M (2)-cholinoceptor function in obesity-related hypertension. Hypertension 1999; 34:1066-1072.
50. Smyth HS, Sleight P, Pickering GW. A quantitative method of assessing baroreflex sensitivity. Circ Res 1969; 24:109-121.
51. Kaushal P, Taylor JC. Inter-relations among declines in arterial distensibility, baroreflex function and respiratory sinus arrhythmia. J Am Coll Cardiol 2002; 39:1524-1530.
52. Brown AM. Receptors under pressure. An update of baroreceptors. Circ Res 1980; 46:1-10.
53. Narkiewicz K, van de Borne P, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98:772-776.
54. Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation 1969; 39:48-54.
55. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165:1192-1198.